References
Amaducci, L., Baldereschi, M., DiCarlo, A., Maggi, S., Scarlato, G., Candelise, L., et al. (1997). Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. International Journal of Epidemiology, 26(5), 995-1002. Bottacchi, E., Corso, G., Tosi, P., Morosini, M. V., De Filippis, G., Santoni, L., et al. (2012). The cost of first-ever stroke in Valle d’Aosta, Italy: linking clinical registries and administrative data. BMC health services research, 12(1), 372. Capri, S., Veneziano, M.A. (2013). Valutazione economica Rivaroxaban, in Rivaroxaban per la prevenzione dell’ictus in pazienti con fibrillazione atriale: risultati di una valutazione di HTA. Quaderni dell'Italian Journal of Public Health, 2(7), 59-79. Carinci, F., Roti, L., Francesconi, P., Gini, R., Tediosi, F., Di Iorio, T., et al. (2007). The impact of different rehabilitation strategies after major events in the elderly: the case of stroke and hip fracture in the Tuscany region. BMC health services research, 7(1), 95. Cesaroni, G., Agabiti, N., Forastiere, F., & Perucci, C. A. (2009). Socioeconomic differences in stroke incidence and prognosis under a universal healthcare system. Stroke, 40(8), 2812 2819. Di Carlo, A., Baldereschi, M., Gandolfo, C., et al. (2003). for the ILSA Working Group. Stroke in an elderly population. Incidence and impact on survival and daily function. The Italian Longitudinal Study on Aging. Cerebrovasc Dis, 16:141-50. Di Gianfilippo, G., Napoli, D., & Santis, D. (2006). L’ictus in Italia: Risultati a 5 Anni de L’Aquila Stroke Registry (1994-1998) e confronto con studi comparabili di popolazione nazionali ed Internazionali per una politica di gestione programmata della patologia. Riv Ital Neurobiol, 2:109 36. Evers, S. M., Struijs, J. N., Ament, A. J., van Genugten, M. L., Jager, J. H. C., & van den Bos, G. A. (2004). International comparison of stroke cost studies. Stroke, 35(5), 1209-1215. Fattore, G., Torbica, A., Susi, A., Giovanni, A., Benelli, G., Gozzo, M., & Toso, V. (2012). The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC neurology, 12(1), 137. Häkkinen, U., Rosenqvist, G., Iversen, T., Rehnberg, C., & Seppälä, T. T. (2015). Outcome, use of resources and their relationship in the treatment of AMI, stroke and hip fracture at European hospitals. Health economics, 24(S2), 116-139. Hays, A. G., Sacco, R. L., Rundek, T., Sciacca, R. R., Jin, Z., Liu, R., et al. (2006). Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke, 37(7), 1715-1719. Hurst, S. A., Forde, R., Reiter-Theil, S., Slowther, A. M., Perrier, A., Pegoraro, R., & Danis, M. (2007). Physicians' views on resource availability and equity in four European health care systems. BMC Health Services Research, 7(1), 137. ISTAT. (2015). Health for all - Italia. from: www.istat.it/it/archivio/14562/ Lucioni, D. C., Mazzi, S., Micieli, G., Sacchetti, M. L., & Toni, D. (2010). Valutazione economica del trattamento con alteplase di pazienti con ictus ischemico in fase acuta, con riferimento all’Italia. PharmacoEconomics Italian Research Articles, 12(2), 91-103. Mahoney, E. M., Wang, K., Arnold, S. V., Proskorovsky, I., Wiviott, S., Antman, E., et al. (2010). Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation, 121(1), 71-79. Masiero, S., Poli, P., Armani, M., Ferlini, G., Rizzello, R., & Rosati, G. (2014). Robotic Upper Limb Rehabilitation after Acute Stroke by NeReBot: Evaluation of Treatment Costs. BioMed research international, 2014. Mureddu, G. F., Tarantini, L., Agabiti, N., Faggiano, P., Masson, S., Latini, R., et al. (2013). Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre?clinical (stage B) heart failure in the elderly. Results from ‘PREDICTOR’, a population based?study in central Italy. European journal of heart failure, 15(10), 1102 1112. Nichols, M., Townsend, N., Luengo-Fernandez, R., Leal, J., Gray, A., Scarborough, P., Rayner, M. (2012). European Cardiovascular Disease Statistics 2012. Brussels: European Heart Network, European Society of Cardiology, Sophia Antipolis. Piscitelli, P., Iolascon, G., Argentiero, A., Chitano, G., Neglia, C., Marcucci, G., et al. (2012). Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clinical interventions in aging, 7, 575. Ravasio, R., Pedone, M. P., & Ratti, M. (2014). Analisi di costo efficacia dei nuovi anticoagulanti orali nella prevenzione dell’ictus in pazienti con fibrillazione atriale non valvolare in Italia. PharmacoEconomics Italian Research Articles, 16(2-3), 1-10. Sarti, C., Rastenyte, D., Cepaitis, Z., Tuomilehto, J. (2000). International trends in mortality from stroke, 1968 to 1994. Stroke, 31:1588-601. Scaletti, A., Lauro, E., Belfiore, P., Zamparelli, B., Liguori, G., & SIHHS (2014). Impatto economico delle Stroke Unit in Campania. Ig. Sanità Pubbl, 70:73 96. Schuetz, C. A., Alperin, P., Guda, S., van Herick, A., Cariou, B., Eddy, D., et al. (2013). A standardized vascular disease health check in europe: a cost-effectiveness analysis. PloS one, 8(7), e66454. Sudlow, C. L. M., Warlow, C. P., & International Stroke Incidence Collaboration. (1997). Comparable studies of the incidence of stroke and its pathological types results from an international collaboration. Stroke, 28(3), 491-499.
